• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Attaining target hemoglobin levels in patients new to dialysis: individualizing therapy based on initial hemoglobin levels.

作者信息

Gregory Nancy

机构信息

East Division of Gambro Healthcare, USA.

出版信息

Nephrol Nurs J. 2004 Nov-Dec;31(6):672-5.

PMID:15686331
Abstract

Incident patients on dialysis typically have Hgb levels that are well below the target range of 11 to 12 g/dL as recommended by the NKF-K/DOQI (NKF 2001). Despite a nationwide emphasis on anemia as a quality indicator, low Hgb levels often persist for months after dialysis is initiated. This report provides an overview of an innovative, evidence-based approach to treating anemia that can help shorten the time required to achieve target Hgb levels in patients new to dialysis.

摘要

相似文献

1
Attaining target hemoglobin levels in patients new to dialysis: individualizing therapy based on initial hemoglobin levels.
Nephrol Nurs J. 2004 Nov-Dec;31(6):672-5.
2
Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.透析开始时及时纠正贫血。贫血患者的病例研究。
Nephrol Nurs J. 2002 Oct;29(5):469-72.
3
Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.促红细胞生成素α在终末期肾病患者中的应用：对美国近期处方模式及血红蛋白结果的分析
Am J Kidney Dis. 2005 Sep;46(3):481-8. doi: 10.1053/j.ajkd.2005.05.018.
4
Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.血液透析患者的方案依从性及达到目标血红蛋白水平的能力。
Nephrol Dial Transplant. 2009 Jun;24(6):1956-62. doi: 10.1093/ndt/gfn780. Epub 2009 Jan 28.
5
Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL.透析患者的生活质量：维持血红蛋白水平在11至12克/分升的益处。
Nephrol Nurs J. 2005 May-Jun;32(3):307-10.
6
Anemia management protocols: providing consistent hemoglobin outcomes.贫血管理方案：实现一致的血红蛋白治疗效果。
Nephrol Nurs J. 2005 Jul-Aug;32(4):423-6.
7
Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.贫血管理方案与促红细胞生成素α的应用：一种算法方法。贫血患者的案例研究。
Nephrol Nurs J. 2002 Jun;29(3):297-300.
8
Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.对于接受化疗的贫血癌症患者，每周一次注射40,000单位促红细胞生成素α的抗贫血效果。
J Med Assoc Thai. 2007 Jun;90(6):1082-8.
9
Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.基于初始血红蛋白水平，在铂类化疗期间早期使用促红细胞生成素α：一项多中心、随机、对照试验结果的分析
Oncologist. 2006 Feb;11(2):206-16. doi: 10.1634/theoncologist.11-2-206.
10
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.血红蛋白水平低于11 g/dL的血液透析患者中，更高剂量的促红细胞生成素α（EPO）与短期死亡风险
Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):932-40. doi: 10.1002/pds.1799.